Ainnova stood out among 18 innovative global start-ups.
Ainnova Tech won the Innov8 Talks pitch competition at FIME 2023, standing out among 18 innovative early- and middle-stage global start-ups.
The recognition underscores the impact of Ainnova's AI-powered approach to early disease detection.
FIME (the Florida International Medical Expo) is one of the Americas' leading medical trade fairs, held at the Miami Beach Convention Center. Its Innov8 Talks track features a pitch competition for innovative early- and middle-stage health-tech companies.
Winning among a strong field of global start-ups highlighted the strength of Ainnova's technology.
Ainnova Tech is a healthcare technology company focused on revolutionizing early disease detection using artificial intelligence. Its platform, VisionAI, analyzes retinal images to detect early markers of diseases such as diabetic retinopathy — with a growing portfolio spanning cardiovascular, metabolic, liver and kidney risk. Ainnova is dedicated to making healthcare more proactive, accessible and efficient.
Source: Featured in Omnia Health Insights ↗
Contact: Ainnova Tech — info@ainnovatech.com